These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21263069)

  • 1. Activation receptor-induced tolerance of mature NK cells in vivo requires signaling through the receptor and is reversible.
    Bolanos FD; Tripathy SK
    J Immunol; 2011 Mar; 186(5):2765-71. PubMed ID: 21263069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous engagement of a self-specific activation receptor induces NK cell tolerance.
    Tripathy SK; Keyel PA; Yang L; Pingel JT; Cheng TP; Schneeberger A; Yokoyama WM
    J Exp Med; 2008 Aug; 205(8):1829-41. PubMed ID: 18606857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional consequences of natural sequence variation of murine cytomegalovirus m157 for Ly49 receptor specificity and NK cell activation.
    Corbett AJ; Coudert JD; Forbes CA; Scalzo AA
    J Immunol; 2011 Feb; 186(3):1713-22. PubMed ID: 21187440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of activation receptor ligand by trogocytosis renders NK cells hyporesponsive.
    Miner CA; Giri TK; Meyer CE; Shabsovich M; Tripathy SK
    J Immunol; 2015 Feb; 194(4):1945-53. PubMed ID: 25582853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection.
    Orr MT; Sun JC; Hesslein DG; Arase H; Phillips JH; Takai T; Lanier LL
    J Exp Med; 2009 Apr; 206(4):807-17. PubMed ID: 19332875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance of NK cells encountering their viral ligand during development.
    Sun JC; Lanier LL
    J Exp Med; 2008 Aug; 205(8):1819-28. PubMed ID: 18606858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ly49H engagement compensates for the absence of type I interferon signaling in stimulating NK cell proliferation during murine cytomegalovirus infection.
    Geurs TL; Zhao YM; Hill EB; French AR
    J Immunol; 2009 Nov; 183(9):5830-6. PubMed ID: 19828630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting Edge: NKG2D Signaling Enhances NK Cell Responses but Alone Is Insufficient To Drive Expansion during Mouse Cytomegalovirus Infection.
    Nabekura T; Gotthardt D; Niizuma K; Trsan T; Jenus T; Jonjic S; Lanier LL
    J Immunol; 2017 Sep; 199(5):1567-1571. PubMed ID: 28760883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain of virulence caused by loss of a gene in murine cytomegalovirus.
    Bubić I; Wagner M; Krmpotić A; Saulig T; Kim S; Yokoyama WM; Jonjić S; Koszinowski UH
    J Virol; 2004 Jul; 78(14):7536-44. PubMed ID: 15220428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation contributes to variability in expression of murine cytomegalovirus m157 and enhances stability of interaction with the NK-cell receptor Ly49H.
    Guseva NV; Fullenkamp CA; Naumann PW; Shey MR; Ballas ZK; Houtman JC; Forbes CA; Scalzo AA; Heusel JW
    Eur J Immunol; 2010 Sep; 40(9):2618-31. PubMed ID: 20662096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral infection transiently reverses activation receptor-mediated NK cell hyporesponsiveness in an MHC class I-independent mechanism.
    Mazumdar B; Bolanos FD; Tripathy SK
    Eur J Immunol; 2013 May; 43(5):1345-55. PubMed ID: 23440763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of murine cytomegalovirus m157 from infected cells and identification of critical residues mediating recognition by the NK cell receptor Ly49H.
    Davis AH; Guseva NV; Ball BL; Heusel JW
    J Immunol; 2008 Jul; 181(1):265-75. PubMed ID: 18566392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections.
    Jensen IJ; Winborn CS; Fosdick MG; Shao P; Tremblay MM; Shan Q; Tripathy SK; Snyder CM; Xue HH; Griffith TS; Houtman JC; Badovinac VP
    PLoS Pathog; 2018 Oct; 14(10):e1007405. PubMed ID: 30379932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand White mice.
    Rodriguez M; Sabastian P; Clark P; Brown MG
    J Immunol; 2004 Nov; 173(10):6312-8. PubMed ID: 15528370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex.
    Fodil-Cornu N; Lee SH; Belanger S; Makrigiannis AP; Biron CA; Buller RM; Vidal SM
    J Immunol; 2008 Nov; 181(9):6394-405. PubMed ID: 18941230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Ly49H Receptor Engagement
    Key PN; Germino J; Yang L; Piersma SJ; Tripathy SK
    Front Immunol; 2019; 10():1692. PubMed ID: 31396217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1.
    Champsaur M; Beilke JN; Ogasawara K; Koszinowski UH; Jonjic S; Lanier LL
    J Immunol; 2010 Jul; 185(1):157-65. PubMed ID: 20530257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells attenuate cytomegalovirus-induced hearing loss in mice.
    Almishaal AA; Mathur PD; Hillas E; Chen L; Zhang A; Yang J; Wang Y; Yokoyama WM; Firpo MA; Park AH
    PLoS Pathog; 2017 Aug; 13(8):e1006599. PubMed ID: 28859161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Requirement of Cytokine and Activation Receptor Triggering for Cytotoxic Control of Murine Cytomegalovirus by NK Cells.
    Parikh BA; Piersma SJ; Pak-Wittel MA; Yang L; Schreiber RD; Yokoyama WM
    PLoS Pathog; 2015 Dec; 11(12):e1005323. PubMed ID: 26720279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAP10 associates with Ly49 receptors but contributes minimally to their expression and function in vivo.
    Tassi I; Le Friec G; Gilfillan S; Takai T; Yokoyama WM; Colonna M
    Eur J Immunol; 2009 Apr; 39(4):1129-35. PubMed ID: 19247984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.